Overview

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Dose-ranging Study in the Treatment of Acne Vulgaris,
Phase:
Phase 2
Details
Lead Sponsor:
Vyome Therapeutics Inc.